Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of clozapine tablets in patients with schizophrenia
ChiCTR2000032289Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clozapine in schizophrenia (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Clozapine plasma concentration. Planned start May 2020; status: not yet recruiting.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2000032289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032289.